Lymphoma Clinical Trials

A listing of Lymphoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1669 clinical trials
None
HD21 for Advanced Stages

Primary objective of the trial is to demonstrate non-inferior efficacy of six cycles of BrECADD compared to six cycles of escalated BEACOPP, each followed by radiotherapy to PET-positive residual lesions 2.5 cm, in terms of progression free survival (efficacy objective). If non-inferior efficacy can be shown, the co-primary objective is …

vincristine
etoposide
cyclophosphamide
lymphoma
doxorubicin
  • 0 views
  • 21 Jun, 2021
  • 1 location
None
Biomarker Driven Intensified ChemoImmunotherapy With Early CNS Prophylaxis

large B-cell lymphoma (DLBCL).

large cell lymphoma
burkitt's lymphoma
t-cell lymphoma
b-cell lymphoma
follicular lymphoma
  • 36 views
  • 23 Jan, 2021
  • 18 locations
None
  • 714 views
  • 10 Oct, 2021
  • 150 locations
None
Study of Capmatinib Efficacy in Comparison With Docetaxel in Previously Treated Participants With Non-small Cell Lung Cancer Harboring MET Exon 14 Skipping Mutation

their epidermal growth factor receptor (EGFR) or anaplastic lymphoma kinase (ALK) genes, will be enrolled in this study. The study drug, capmatinib (also known as INC280), is an oral drug that is

epidermal growth factor
measurable disease
growth factor
lung carcinoma
docetaxel
  • 0 views
  • 18 Jul, 2021
  • 44 locations
None
AZD4573 in Novel Combinations With Anti-cancer Agents in Patients With Advanced Blood Cancer.

This is a modular, multicentre, open-label, non-randomised, Phase I/II, dose-setting and expansion study including an intra-participant ramp-up. AZD4573 will be administered intravenously, in novel combinations with anti-cancer agents, to participants with relapsed/refractory haematological malignancies.

  • 0 views
  • 19 Oct, 2021
  • 34 locations
None
Dietary Intervention in Follicular Lymphoma

A dietary intervention study in patients with Follicular Lymphoma (FL) Stage III/IV to assess the ability of several dietary factors to induce apoptosis, inhibit cell proliferation and

rituximab
  • 21 views
  • 07 Nov, 2020
  • 1 location
None
Itacitinib + Everolimus in Hodgkin Lymphoma

This is an open-label, single-group, Phase I/II study of itacitinib in combination with everolimus in subjects with relapsed or refractory classical Hodgkin lymphoma (cHL).

cancer
lymphoma
carcinoma
positron emission tomography/computed tomography
everolimus
  • 1 views
  • 06 Aug, 2021
  • 1 location
None
Gonadal Dysfunction in Male Long-term Survivors of Malignant Lymphoma; Vitality

This study is a prospective non-randomised open label multicenter phase two study in male long-term survivors of malignant lymphoma including Hodgkin Lymphoma (HL) and Diffuse Large B-Cell

testosterone level
testosterone
sexual dysfunction
androgel
cancer
  • 0 views
  • 19 Jun, 2021
  • 3 locations
None
A Study of KRN125 in Patients With Multiple Myeloma and Malignant Lymphoma

To determine if KRN125 is non-inferior to filgrastim for the mobilization of hematopoietic stem cells into the peripheral blood in patients with multiple myeloma.

  • 0 views
  • 22 Aug, 2021
  • 1 location
None
Xcellerated T CellsTM for Non-Hodgkin s Lymphoma (NHL) Patients

This is a Phase II single arm study of a novel T cell immunotherapy in patients with indolent non-Hodgkin’s lymphoma (NHL). Eligible patients will have relapsed or refractory disease

marginal zone lymphoma
mantle cell lymphoma
measurable disease
b-cell lymphoma
platelet count
  • 86 views
  • 07 Nov, 2020
  • 18 locations